Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cells
|
June 2, 2021
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Suresh Gopi Kalathil, Yasmin Thanavala
Cellular Immunology
|
January 14, 2021
Importance of myeloid derived suppressor cells in cancer from a biomarker perspective
Suresh Gopi Kalathil, Yasmin Thanavala
Cancer Immunology, Immunotherapy : CII
|
February 25, 2016
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
Suresh Gopi Kalathil, Yasmin Thanavala
Annals of the American Thoracic Society
|
November 24, 2015
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease
Tariq A Bhat, Louis Panzica, Suresh Gopi Kalathil, et al.
JCI Insight
|
August 9, 2019
Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy
Suresh Gopi Kalathil, Alan Hutson, Joseph Barbi, et al.
Oncoimmunology
|
October 26, 2020
Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients
Suresh Gopi Kalathil, Katy Wang, Alan Hutson, et al.
Oncoimmunology
|
November 18, 2016
Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib
Suresh Gopi Kalathil, Amit Anand Lugade, Renuka Iyer, et al.
JCI Insight
|
August 20, 2016
PD-1<sup>+</sup> and Foxp3<sup>+</sup> T cell reduction correlates with survival of HCC patients after sorafenib therapy
Suresh Gopi Kalathil, Amit Anand Lugade, Austin Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 29, 2020
Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke
Tariq A Bhat, Suresh Gopi Kalathil, Austin Miller, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 15, 2014
T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease
Suresh Gopi Kalathil, Amit Anand Lugade, Vandana Pradhan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cells
|
June 2, 2021
Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
Suresh Gopi Kalathil, Yasmin Thanavala
Cellular Immunology
|
January 14, 2021
Importance of myeloid derived suppressor cells in cancer from a biomarker perspective
Suresh Gopi Kalathil, Yasmin Thanavala
Cancer Immunology, Immunotherapy : CII
|
February 25, 2016
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
Suresh Gopi Kalathil, Yasmin Thanavala
Annals of the American Thoracic Society
|
November 24, 2015
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary Disease
Tariq A Bhat, Louis Panzica, Suresh Gopi Kalathil, et al.
JCI Insight
|
August 9, 2019
Augmentation of IFN-γ+ CD8+ T cell responses correlates with survival of HCC patients on sorafenib therapy
Suresh Gopi Kalathil, Alan Hutson, Joseph Barbi, et al.
Oncoimmunology
|
October 26, 2020
Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients
Suresh Gopi Kalathil, Katy Wang, Alan Hutson, et al.
Oncoimmunology
|
November 18, 2016
Endothelial progenitor cell number and ERK phosphorylation serve as predictive and prognostic biomarkers in advanced hepatocellular carcinoma patients treated with sorafenib
Suresh Gopi Kalathil, Amit Anand Lugade, Renuka Iyer, et al.
JCI Insight
|
August 20, 2016
PD-1<sup>+</sup> and Foxp3<sup>+</sup> T cell reduction correlates with survival of HCC patients after sorafenib therapy
Suresh Gopi Kalathil, Amit Anand Lugade, Austin Miller, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 29, 2020
Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke
Tariq A Bhat, Suresh Gopi Kalathil, Austin Miller, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 15, 2014
T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease
Suresh Gopi Kalathil, Amit Anand Lugade, Vandana Pradhan, et al.
Page
of 2